drug protocol number

RC20/370/R

drug sponsor

KAIMRC

drug study

SARS-CoV-2 inactivated vaccine (Candidate vaccine) - Sinovac

drug trial site

King Abdulaziz Medical City NG (Riyadh)

drug status

Rejected

drug phase